Joan Bladé
- Hematology top 0.01%
- Multiple Myeloma Research and Treatments 271
- Oncology top 0.2%
- Peptidase Inhibition and Analysis 72
- Cancer Treatment and Pharmacology 59
- Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research 38
- Myeloproliferative Neoplasms: Diagnosis and Treatment 32
- Molecular Biology top 0.5%
- Protein Degradation and Inhibitors 96
- Amyloidosis: Diagnosis, Treatment, Outcomes 48
-
- HIV/AIDS drug development and treatment 18
- Co-authors
- Laura RosiñolJesús F. San MiguelRobert A. KylePieter SonneveldJuan José LahuertaMaría Teresa CibeiraHeinz LudwigMario Boccadoro
- Cited by
- HematologyOncologyGenetics
- Journals
- Blood (73 papers)Journal of Clinical Oncology (30 papers)British Journal of Haematology (29 papers)
- Partner nations
- SpainUnited StatesFrance
In The Last Decade
Joan Bladé
315 papers receiving 14.5k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Hematology 12.1k
- Oncology 6.9k
- Genetics 2.4k
- Molecular Biology 9.3k
- Pathology and Forensic Medicine 997
Countries citing papers authored by Joan Bladé
This map shows the geographic impact of Joan Bladé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joan Bladé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joan Bladé more than expected).
Fields of papers citing papers by Joan Bladé
This network shows the impact of papers produced by Joan Bladé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joan Bladé. The network helps show where Joan Bladé may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Joan Bladé, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 9 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 2 | |
| 7 | 2021 | 7 | |
| 8 | 2020 | 38 | |
| 9 | 2020 | 7 | |
| 10 | 2020 | 14 | |
| 11 | 2018 | 16 | |
| 12 | 2018 | 5 | |
| 13 | 2017 | 4 | |
| 14 | 2017 | 9 | |
| 15 | 2017 | 1 | |
| 16 | 2017 | 5 | |
| 17 | 2013 | 150 | |
| 18 | 2013 | 348 | |
| 19 | 2009 | 49 | |
| 20 | 2008 | 193 |
About Joan Bladé
Joan Bladé is a scholar working on Hematology, Genetics, Oncology, Molecular Biology and Infectious Diseases, having authored 324 papers that have together received 14.8k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (271 papers), Protein Degradation and Inhibitors (96 papers), Peptidase Inhibition and Analysis (72 papers), Cancer Treatment and Pharmacology (59 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (48 papers), Chronic Lymphocytic Leukemia Research (38 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (32 papers) and HIV/AIDS drug development and treatment (18 papers). The work is most often cited by research in Hematology (12.1k citations), Oncology (6.9k citations), Genetics (2.4k citations), Molecular Biology (9.3k citations) and Pathology and Forensic Medicine (997 citations). Joan Bladé has collaborated with scholars based in Spain, United States and France. Frequent co-authors include Laura Rosiñol, Jesús F. San Miguel, Robert A. Kyle, Pieter Sonneveld, Juan José Lahuerta, María Teresa Cibeira, Heinz Ludwig, Mario Boccadoro, Philip R. Greipp and David H. Vesole. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, Haematologica and European Journal Of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.